Status: Recruiting
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy. Edetate calcium disodium or succimer may help to lower the level of metals found in the bone marrow and blood and may help to control the disease and/or improve response to chemotherapy.
Participants needed: 58
Trial details
Phase: Phase 1Age: 1+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Mar 2, 2026Locations: 1
Eligibility criteria
Patients ≥18 years of age, or their legally authorized representative (LAR), mus... [+20]
Nursing and pregnant females. Should a woman become pregnant or suspect she is p... [+2]